The Impact of Kinase Insert Domain (KDR) Gene Polymorphism rs2305948 on Clopidogrel Resistance in Iraqi Patients Undergoing Elective Percutaneous Coronary Intervention (PCI)

INTRODUCTION: Clopidogrel, the first-choice antiplatelet agent for patient undergoing Percutaneous Coronary Intervention (PCI) along with Aspirin. Clopidogrel resistance is one of the major obstacles that cause MACE and failure of PCI. Kinase Insert Domain (KDR) gene responsible for VEGFR2 coding, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Ali A., Amber, Khalid I., Hadi, Najah R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Medical sciences 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780779/
https://www.ncbi.nlm.nih.gov/pubmed/33417661
http://dx.doi.org/10.5455/aim.2020.28.202-208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780779/
https://www.ncbi.nlm.nih.gov/pubmed/33417661
http://dx.doi.org/10.5455/aim.2020.28.202-208

Ejemplares similares